Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xopenex vs. Racemic Albuterol for Pediatric Acute Asthma
NCT00585039Phase 4Completed
- Sponsor
- Phoenix Children's
- Start
- Sep 2005
- Primary completion
- Mar 2009
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levalbuterol in asthma, sponsored by Phoenix Children's. Primary endpoint: Forced Expiratory Volume in 1 Second at 4 hours. Started Sep 2005; status: completed.
02
Drugs
levalbuterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00585039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00585039.